Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
ANTI-HER-2 ANTIBODY-GRANULOCYTE REGULATORY FACTOR FUSION PROTEIN, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF
Document Type and Number:
WIPO Patent Application WO/2023/011662
Kind Code:
A1
Abstract:
Provided are an anti-Her-2 antibody-granulocyte regulatory factor fusion protein, a preparation method therefor and an application thereof. Specifically, this relates to a fusion protein, a single chain of the fusion protein comprising the following elements fused together: (a) a first protein element; (b) a second protein element; and (c) optionally, a joint element located between the first protein element and the second protein element. The first protein element is an antigen recognition module, for example, a protein element of an anti-Her-2 antibody or an active fragment thereof; the second protein element is a granulocyte colony stimulating factor. The present fusion protein has advantages in precise recognition, immunotherapy, controllable toxicity, and enhanced ADCC, and also has the synergistic effect of high-efficiency tumor cell killing activity, as well as low toxicity and side effects.

Inventors:
CHEN YI (CN)
CAI ZELING (CN)
LI PENG (CN)
ZHANG RONGHUI (CN)
SONG YAQIN (CN)
ZHANG LIQIANG (CN)
Application Number:
PCT/CN2022/110926
Publication Date:
February 09, 2023
Filing Date:
August 08, 2022
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
SHANGHAI CELGEN BIO PHARMACEUTICAL CO LTD (CN)
International Classes:
C07K19/00; A61K38/19; A61K47/65; A61K47/68; A61P35/00; C12N15/62
Foreign References:
US20030187225A12003-10-02
CN103755812A2014-04-30
CN1410450A2003-04-16
CN1311332A2001-09-05
Other References:
CRUZ, J. S. D. ET AL.: "Anti-HER2/neu IgG3–(IL-2) and anti-HER2/neu IgG3–(GM-CSF) promote HER2/neu processing and presentation by dendritic cells: Implications in immunotherapy and vaccination strategies", MOLECULAR IMMUNOLOGY, vol. 43, 23 May 2005 (2005-05-23), pages 667 - 676, XP025037173, DOI: 10.1016/j.molimm.2005.04.007
FANG YONGXIANG, FENG HAIYAN, MOSCOW, JING ZHIZHONG: "Cytokine Fusion Protein Technology and Its Application Prospects", CHINESE JOURNAL OF CELLULAR AND MOLECULAR IMMUNOLOGY, FOURTH MILITARY MEDICAL UNIVERSITY, XI'AN, CN, vol. 25, no. 9, 31 December 2009 (2009-12-31), CN , pages 856 - 859, XP093031509, ISSN: 1007-8738, DOI: 10.13423/j.cnki.cjcmi.005177856
GUO XIN: " Protective Immune Response against HER2/neu Expressing Tumors Induced by Inoculation of Novel Anti-HER2/neu Cytokine Fusion Proteins with Soluble Protein Antigen Conjugates", INTERNATIONAL JOURNAL OF BIOLOGICALS, vol. 29, no. 6, 31 December 2006 (2006-12-31), pages 279 - 279, XP093031514
Attorney, Agent or Firm:
XU & PARTNERS, LLC. (CN)
Download PDF: